Allentown pharmaceutical firm expanding to help create COVID-19 vaccines

December 3, 2020
Garry Morefield of VaxForm, left, and Kyle Flanigan of US Specialty Formulations at Ben Franklin Tech Ventures in Bethlehem. PHOTO/FILE

An Allentown pharmaceutical manufacturing company, U.S. Specialty Formulations, is expanding again to continue its work developing a COVID-19 vaccine in partnership with VaxForm of Bethlehem. The expansion is expected to create at least 97 high-paying jobs at the company.USSF will expand its current 41,000-square-foot facility and request an FDA Emergency Use Approval for the release of a COVID-19 oral and injectable vaccine that should be available by mid-2021.

The company will be making renovations and acquiring new equipment to bolster its efforts. USSF is receiving funding from the state Department of Community and Economic Development in the form of a $291,000 Pennsylvania First grant and was encouraged to apply for a $2.4 million Pennsylvania Industrial Development Authority loan to help with the expansion.

The governor’s office noted that the company has committed to investing at least $5.2 million into the project.

“There will be a global demand for COVID-19 vaccines, and investments like this can help position our commonwealth for success in recovery from this pandemic,” said Gov. Tom Wolf. “My administration is eager to support the growth and job creation of businesses stepping up and offering solutions as we continue to battle this virus and keep our communities healthy and safe.”

Read More

Comments are closed.